Differential inhibitor sensitivity between human kinases VRK1 and VRK2.
Human vaccinia-related kinases (VRK1 and VRK2) are atypical active Ser-Thr kinases implicated in control of cell cycle entry, apoptosis and autophagy, and affect signalling by mitogen activated protein kinases (MAPK). The specific structural differences in VRK catalytic sites make them suitable cand...
Main Authors: | Marta Vázquez-Cedeira, Iria Barcia-Sanjurjo, Marta Sanz-García, Ramiro Barcia, Pedro A Lazo |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3150407?pdf=render |
Similar Items
-
The C/H3 domain of p300 is required to protect VRK1 and VRK2 from their downregulation induced by p53.
by: Alberto Valbuena, et al.
Published: (2008-01-01) -
Modulation of interleukin-1 transcriptional response by the interaction between VRK2 and the JIP1 scaffold protein.
by: Sandra Blanco, et al.
Published: (2008-01-01) -
Axonal Neuropathy, Microcephaly and VRK1 Mutations
by: J Gordon Millichap, et al.
Published: (2014-02-01) -
VRK1 Depletion Facilitates the Synthetic Lethality of Temozolomide and Olaparib in Glioblastoma Cells
by: Elena Navarro-Carrasco, et al.
Published: (2021-06-01) -
Downregulation of VRK1 by p53 in response to DNA damage is mediated by the autophagic pathway.
by: Alberto Valbuena, et al.
Published: (2011-02-01)